Insights

Innovative Focus ObsEva specializes in developing novel therapeutics aimed at improving women's reproductive health and pregnancy, presenting opportunities for partnerships in women’s health Medtech and personalized medicine solutions.

Recent Leadership Change With the appointment of a new CEO in May 2023, there may be strategic shifts or renewed focus areas that present opportunities for collaboration or targeted outreach related to innovation and growth initiatives.

Funding and Growth Having secured $75 million in funding and completed a notable Series A round led by major investors, ObsEva is poised for expansion and development, offering potential sales avenues for biotech partners and service providers.

Research and Development Focused on advancing therapeutics for reproductive health, ObsEva’s pipeline and clinical-stage projects present opportunities to offer complementary research tools, clinical services, or technology platforms.

Market Focus Operating with a small team but significant investor backing, ObsEva’s strategic priorities in women's health suggest potential for targeted partnership opportunities in clinical trials, regulatory consulting, and specialized healthcare solutions.

Similar companies to ObsEva SA

ObsEva SA Tech Stack

ObsEva SA uses 8 technology products and services including WordPress, Google Fonts API, Reveal.js, and more. Explore ObsEva SA's tech stack below.

  • WordPress
    Content Management System
  • Google Fonts API
    Font Scripts
  • Reveal.js
    Javascript Frameworks
  • jQuery UI
    Javascript Libraries
  • Google Analytics
    Web Analytics
  • Yii
    Web Frameworks
  • Understrap
    Web Platform Extensions
  • Apache HTTP Server
    Web Servers

Media & News

ObsEva SA's Email Address Formats

ObsEva SA uses at least 2 format(s):
ObsEva SA Email FormatsExamplePercentage
First.Last@obseva.chJohn.Doe@obseva.ch
81%
Last@obseva.chDoe@obseva.ch
19%
First.Last@obseva.comJohn.Doe@obseva.com
98%
Last.First@obseva.comDoe.John@obseva.com
2%

Frequently Asked Questions

Where is ObsEva SA's headquarters located?

Minus sign iconPlus sign icon
ObsEva SA's main headquarters is located at Plan-Les-Ouates, Geneva 1228 CH. The company has employees across 2 continents, including EuropeNorth America.

What is ObsEva SA's stock symbol?

Minus sign iconPlus sign icon
ObsEva SA is a publicly traded company; the company's stock symbol is OBSVF.

What is ObsEva SA's official website and social media links?

Minus sign iconPlus sign icon
ObsEva SA's official website is obseva.com and has social profiles on LinkedIn.

What is ObsEva SA's SIC code NAICS code?

Minus sign iconPlus sign icon
ObsEva SA's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does ObsEva SA have currently?

Minus sign iconPlus sign icon
As of September 2024, ObsEva SA has approximately 12 employees across 2 continents, including EuropeNorth America. Key team members include Vice President Chemistry, Manufacturing And Control: J. P.Senior Manager Regulatory Affairs: A. P.Board Member & Executive Consultant: L. M.. Explore ObsEva SA's employee directory with LeadIQ.

What industry does ObsEva SA belong to?

Minus sign iconPlus sign icon
ObsEva SA operates in the Biotechnology Research industry.

What technology does ObsEva SA use?

Minus sign iconPlus sign icon
ObsEva SA's tech stack includes WordPressGoogle Fonts APIReveal.jsjQuery UIGoogle AnalyticsYiiUnderstrapApache HTTP Server.

What is ObsEva SA's email format?

Minus sign iconPlus sign icon
ObsEva SA's email format typically follows the pattern of First.Last@obseva.ch. Find more ObsEva SA email formats with LeadIQ.

How much funding has ObsEva SA raised to date?

Minus sign iconPlus sign icon
As of September 2024, ObsEva SA has raised $75M in funding. The last funding round occurred on Aug 08, 2019 for $75M.

When was ObsEva SA founded?

Minus sign iconPlus sign icon
ObsEva SA was founded in 2012.
ObsEva SA

ObsEva SA

Biotechnology ResearchGeneva, Switzerland11-50 Employees

Innovating Women’s Reproductive Health and Pregnancy Therapeutics

ObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy.

For more information, please visit www.ObsEva.com.

Section iconCompany Overview

Headquarters
Plan-Les-Ouates, Geneva 1228 CH
Website
obseva.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
OBSVF
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2012
Employees
11-50

Section iconFunding & Financials

  • $75M

    ObsEva SA has raised a total of $75M of funding over 5 rounds. Their latest funding round was raised on Aug 08, 2019 in the amount of $75M.

  • $1M

    ObsEva SA's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $75M

    ObsEva SA has raised a total of $75M of funding over 5 rounds. Their latest funding round was raised on Aug 08, 2019 in the amount of $75M.

  • $1M

    ObsEva SA's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.